NCT05020067View on ClinicalTrials.gov

Impact on Xerostomia for Nasopharyngeal Carcinoma Patients Treated With or Without Superficial Parotid Lobe-sparing Intensity-modulated Radiotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 12, 2018

Primary Completion Date

November 6, 2019

Study Completion Date

August 17, 2021

Conditions
Nasopharyngeal CarcinomaRadiation-induced Xerostomia
Interventions
RADIATION

superficial parotid lobe-sparing intensity-modulated radiotherapy

The superficial parotid lobe was contoured as an OAR, and V26 (the percentage volume receiving 26 Gy or more) in the superficial parotid lobe was constrained to be less than 30%.

Trial Locations (1)

510060

Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT05020067 - Impact on Xerostomia for Nasopharyngeal Carcinoma Patients Treated With or Without Superficial Parotid Lobe-sparing Intensity-modulated Radiotherapy | Biotech Hunter | Biotech Hunter